New Therapeutic Antibody Discovery Collaboration New Therapeutic Antibody Discovery Collaboration Proprietary antibody libraries to help discover therapeutic antibodies against multiple targets
clinical-collaboration-with-Amgen clinical-collaboration-with-Amgen Collaboration to study Boehringer Ingelheim’s SOS1::pan-KRAS Inhibitor in combination with Amgen’s KRASG12C Inhibitor
Boehringer Ingelheim: Discover the app set to transform animal care in rural India Boehringer Ingelheim: Discover the app set to transform animal care in rural India Learn about the app set to transform animal care in rural India. Women will be empowered and goat welfare will be promoted. From idea to app!
Access to Healthcare: How we help underserved communities Access to Healthcare: How we help underserved communities Access to healthcare is not a given for everyone. We are partnering with an organization in Rome to help underserved communities.
NeO - smart and sustainable vaccines NeO - smart and sustainable vaccines The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.
Spotlight on GPP Spotlight on GPP Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
CHMP_opinion_Nintedanib_SSc-ILD CHMP_opinion_Nintedanib_SSc-ILD Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis
LongRange LongRange Longrange® is effective in the control of most internal and external parasites of cattle: gastrointestinal roundworms, lungworms, grubs, mites.
Investing in our people University of Medicine Excellence Investing in our people University of Medicine Excellence Almost one thousand of our employees have graduated from a program developed together with Harvard Medical School’s Executive Education.
More Health Overview More Health Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Implementing the generalized pustular psoriasis (GPP) Charter Implementing the generalized pustular psoriasis (GPP) Charter Read more about the projects are implementing the generalized pustular psoriasis (GPP) Charter
Keep water clean Keep water clean Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water.
global-top-employer global-top-employer For the first time, Boehringer Ingelheim receives the award as a Global Top Employer as well as individual awards in 27 countries.
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
Boehringer Ingelheim partners with PetMedix Boehringer Ingelheim partners with PetMedix Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals
Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award announced Three winner awarded 25,000 euro each for their research.
Building Successful Partnerships in Animal Health Building Successful Partnerships in Animal Health Christoph Vetten, Head of Transactions Animal Health, shares his perspectives on how building successful collaborations can drive innovation.
2024 half year results innovation progress 2024 half year results innovation progress First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Financial health Financial health We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.
Breakthrough Designation granted in US and China Breakthrough Designation granted in US and China SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
Spesolimab prevents GPP flares Spesolimab prevents GPP flares Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
FRONTLINE FRONTLINE indicated for the treatment and prevention of fleas, ticks and chewing lice in dogs and cats, and aids in the control of sarcoptic mange in dogs.
Groundbeaking of vaccine production center in France Groundbeaking of vaccine production center in France Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
Henke-Sass Wolf develop needle free device Henke-Sass Wolf develop needle free device Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs